The treatment of multiple sclerosis (MS) has changed over the last 20 years. All
immunotherapeutic drugs target relapsing remitting MS (RRMS) and it still remains a …

Cancer is the second leading cause of death affecting nearly one in two people, and the
appearance of new cases is projected to rise by> 70% by 2030. To effectively combat the …

An increase of multiple sclerosis (MS) incidence has been reported during the last decade,
and this may be connected to environmental factors. This review article aims to encapsulate …

Autoimmune disorders are characterized by aberrant T cell and B cell reactivity to the body's
own components, resulting in tissue destruction and organ dysfunction. Autoimmune …

Background: It is well known that the cerebrospinal fluid (CSF) concentrations of free light
chains (FLC) and immunoglobulin G (IgG) are elevated in multiple sclerosis patients (MS) …

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system and is
considered to be the leading non-traumatic cause of neurological disability in young adults …

Multiple sclerosis (MS) is a deleterious autoimmune and demyelinating disorder of the
central nervous system with debilitating sensory and motor complications. There is still no …

Multiple Sclerosis (MS) is a serious autoimmune disease. The patient in an advanced state
of the disease has restrained mobility and remains handicapped. It is therefore …

Many autoimmune diseases, including multiple sclerosis (MS), rheumatoid arthritis (RA),
and celiac disease (CD), arise from improper immune system recognition of self or benign …

Background Gut commensal microbiota has been identified as a potential environmental risk
factor for multiple sclerosis (MS), and numerous studies have linked the commensal …